The present disclosure relates to a class of mammalian heat shock factor (HSF) inhibitors, to pharmaceutical compositions comprising these inhibitors as well as to methods for using the inhibitors. The inhibitors inhibit stress-induced expression from heat shock gene promoters. Furthermore, the inhibitors are cytotoxic to a variety of human cancer cells types.
[EN] INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF<br/>[FR] INHIBITEURS DU FACTEUR DE CHOC THERMIQUE ET UTILISATIONS DE CEUX-CI
申请人:HSF PHARMACEUTICALS
公开号:WO2018050656A2
公开(公告)日:2018-03-22
The present disclosure relates to a class of mammalian heat shock factor (HSF) inhibitors, to pharmaceutical compositions comprising these inhibitors as well as to methods for using the inhibitors. The inhibitors inhibit stress-induced expression from heat shock gene promoters. Furthermore, the inhibitors are cytotoxic to a variety of human cancer cells types.
Synthesis of Unsaturated &#945-Acyloxybenzothiazoleamides via the Passerini Three-Component Reaction
4-Benzothiazol-2-ylamino-4-oxo-2-butenoic acid, prepared from reaction of 2-aminobenzothiazole and maleic
anhydride, are used as an acid component in Passerini three-component reaction, under solvent-free media, to produce
unsaturated α-benzothiazole acyloxyamides in good yields.